Sort
82,697 grants matching “vaccine development”
Center for Immunotherapeutic Transport Oncophysics
$1,865,321Haifa Shen · Methodist Hospital Research Institute · U54 · FY2018 · CA
Lyme Disease: B cell epitope discovery and mechanisms of antibody protection
$1,865,211Nicholas J Mantis · Nysdoh/Health Research, Inc. · N01 · FY2023 · AI
DEVELOPMENT OF A RECOMBINANT VSV-BASED VACCINE FOR NIPAH VIRUS
$1,864,897University Of Texas Medical Branch At Galveston · · FY2019 · Department of the Army
Vaccine and Infection Induced Immunity in the Young and Aged
$1,864,381Rafi Ahmed · Emory University · U19 · FY2024 · AI
Epithelial Ovarian Cancer Program Project
$1,863,957Sloan-Kettering Institute For Cancer Res · P01 · FY2005 · CA
Virus Ecology Unit
$1,863,857Vincent Munster · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Fred Hutchinson Cancer Research Center Lung SPORE
$1,863,485A. McGarry Houghton · Fred Hutchinson Cancer Research Center · P50 · FY2021 · CA
Feasibility for Development of a Liposome/LNP Displaying an HIV Env Trimer Protein and Containing/Incorporating an mRNA
$1,863,405Timothy R Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2024 · AI
University of Washington Vaccine and Treatment Evaluation Unit
$1,863,350Anna Wald · University Of Washington · UM1 · FY2023 · AI
Project 4: Computational panbetaCoV immunogen design
$1,863,181Rory Henderson · Duke University · P01 · FY2021 · AI
Structure and function of eukaryotic DNA transposases
$1,862,992Frederick Dyda · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Prevention of AIDS
$1,862,956Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
A-Z Clinical Trials Unit
$1,862,682Paul A. Goepfert · University Of Alabama At Birmingham · UM1 · FY2023 · AI
Live attenuated vaccines for epidemic and pandemic flu
$1,862,415Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U01 · FY2008 · AI
HIV VACCINE CLINICAL TRIAL UNIT AT SAINT LOUIS UNIVER
$1,861,934Saint Louis University · U01 · FY2005 · AI
Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication
$1,861,737Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2024 · AI
Virus-Host Interactions: Induction and Evasion of Host Innate Immunity
$1,861,412Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Thymic vaccination: Manipulating the T cell repertoire
$1,859,942Dana-Farber Cancer Institute · R01 · FY2002 · AI
Project 1: Immunogens and Manufacturing
$1,859,000Harriet L Robinson · Geovax, Inc. · U01 · FY2012 · AI
Chimpanzee Biomedical Research Program Limited Competition (U42)
$1,858,987M. Babette Fontenot · University Of Louisiana At Lafayette · U42 · FY2012 · OD
Prevention of AIDS
$1,858,866Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
The Molecular Pathogenesis of Varicella Zoster Virus Infection
$1,858,372Maria Acena Nagel · University Of Colorado Denver · P01 · FY2016 · AG
Epigenomic analysis of primary immune cells from young and old animals
$1,858,191Myong-Hee Sung · National Institute On Aging · ZIA · FY2018 · AG
DEVELOPMENT OF A RECOMBINANT VSV-BASED VACCINE FOR LASSA FEVER
$1,858,169University Of Texas Medical Branch At Galveston · · FY2019 · Defense Health Agency
Integrase Defective Lentiviral Vector (IDLV)-ENV Immunogen Strategy for an HIV Vaccine
$1,858,150Mary E. Klotman · Duke University · P01 · FY2016 · AI